First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Journal
The Lancet
Journal Volume
389
Journal Issue
10072
Pages
917-929
Date Issued
2017
Author(s)
Soria J.-C.
Tan D.S.W.
Chiari R.
Wu Y.-L.
Paz-Ares L.
Wolf J.
Geater S.L.
Orlov S.
Cortinovis D.
Hochmair M.
Cortot A.B.
Tsai C.-M.
Moro-Sibilot D.
Campelo R.G.
McCulloch T.
Sen P.
Dugan M.
Pantano S.
Branle F.
Massacesi C.
de Castro G.
Jr
SDGs
Publisher
Lancet Publishing Group
Type
journal article